Vice President, Investor Relations & Corporate Communications
Hiring Company
About the Role
Greater San Francisco, CA Area (Hybrid - Headquarter location)
The Company is in search of a Vice President for Investor Relations and Corporate Communications. This executive will be instrumental in establishing and leading an integrated organization during a critical phase of the company's growth. The successful candidate will be responsible for developing and executing comprehensive strategies that align with the company's corporate objectives and long-term value creation. This role involves serving as a key point of contact for the investment community, preparing for various investor engagements, and ensuring consistent and impactful messaging. The Vice President will also be tasked with building and scaling the function, including recruiting and developing a high-performing team, and will be expected to have a strong background in the biotechnology or pharmaceutical industry, particularly in the areas of oncology or precision medicine. Applicants for the Vice President position at the company should have a Bachelor's degree in a relevant field, with an MBA or advanced scientific degree preferred, and at least 15 years of leadership experience in investor relations, corporate communications, or related roles. The role requires a strategic thinker with a proven track record in building trusted relationships, exceptional communication skills, and the ability to operate effectively in a fast-paced, high-growth environment. Experience in supporting the evolution of a company from clinical to commercial stage, as well as a background in capital markets transactions and commercial product launches, is highly valued. The ideal candidate will be a collaborative leader with a strong sense of integrity, the ability to manage under pressure, and a commitment to the mission of the company in the field of precision medicine.
Functions:
- Finance
- Marketing
Compensation
USD $309,000-$381,000 (salary) per year
About the Company
Influential biotechnology company
Industry
Biotechnology
Type
Public Company
Age
employees
51-200